Add-on Acquisition • Life Science

L2P Research Acquires Metis Laboratories

On February 28, 2020, L2P Research acquired life science company Metis Laboratories

Acquisition Context

This is L2P Research’s 1st transaction in the Life Science sector.
This is L2P Research’s 1st transaction in the United States.
This is L2P Research’s 1st transaction in New York.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	February 28, 2020
Target	Metis Laboratories
Sector	Life Science
Buyer(s)	L2P Research
Deal Type	Add-on Acquisition

Target Company

Metis Laboratories

Ronkonkoma, New York, United States

Metis Laboratories, Inc. provides radiotracer services for pharma, biotech, and academic organizations across the world. Metis offer standard and specialized services in the areas of radioligand binding assays (HTS), receptor occupancy determinations, autoradiography, Quantitative Whole-Body autoradiography, ADME-PK, small animal imaging, and custom radiolabeling & synthesis. Metis Laboratories was established in 2010 and is based in Ronkonkoma, New York.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

L2P Research

Pennsylvania, United States

Category	Company
Sector	Life Science

DESCRIPTION

L2P Research LLC is a research organization that provides integrated R&D support in all the key areas of Pharmaceutical development. With a large worldwide customer base, L2P provides a complete array of research services as required for Investigational New Drug Applications (IND).

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: New York	1 of 1
Country: United States	1 of 1
Year: 2020	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - New York M&A - United States M&A - 2020 M&A